Melatonin Level and Risk for Type 2 Diabetes–in Reply
-
2013/08/07
-
Details
-
Personal Author:
-
Description:In Reply: Drs. Abbott and Zee comment on the possibility of lower urinary melatonin levels serving as a marker for underlying circadian misalignment related to cumulative shiftwork. We have also contemplated the possibility that melatonin levels are simply a reporter of circadian alignment rather than a marker for abnormal glucose metabolism. Melatonin levels among individuals in the Nurses' Health Study (NHS) have been shown to be inversely associated with the number of night shifts performed in the 2 weeks preceding the measurement, whereas no association was found between melatonin levels and the total number of years of previous shift work for individuals in the NHS. This suggests that shift work likely does not have a sustained effect on melatonin secretion. Additionally, the association of increased shift work with increased risk of incident type 2 diabetes shown in the NHS cohort appeared to be largely mediated by increased body mass index, whereas the association of melatonin with incident type 2 diabetes in our study was independent of body mass index. Nevertheless, we think that Abbott and Zee raise an important issue about the relationship between other forms of chronic circadian misalignment and melatonin secretion. If the low levels of nocturnal melatonin secretion within our cohort were indeed attributable to circadian misalignment due to factors other than prior or current shift work, then the association between low melatonin secretion and incident type 2 diabetes could simply represent an association of circadian misalignment and incident type 2 diabetes. Careful studies are needed to delineate which circadian intervention may be suited to beneficially affect glucose metabolism and whether melatonin levels are a modifiable risk factor. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0098-7484
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:310
-
Issue:5
-
NIOSHTIC Number:nn:20051933
-
Citation:JAMA 2013 Aug; 310(5):537
-
Contact Point Address:Ciaran J. McMullan, MD, Brigham and Women's Hospital, 41 Avenue Louis Pasteur, Ste 121, Boston, MA 02115
-
Email:cmcmullan1@partners.org
-
CAS Registry Number:
-
Federal Fiscal Year:2013
-
NORA Priority Area:
-
Performing Organization:Brigham and Women's Hospital, Inc., Boston, Massachusetts
-
Peer Reviewed:False
-
Start Date:20100801
-
Source Full Name:Journal of the American Medical Association
-
End Date:20190831
-
Collection(s):
-
Main Document Checksum:urn:sha-512:ac991b9aee9e39e7ee23c0c0a0f0dc4908fb1d4af81013581d5453bda32554966ff9e9365ed468e5f14f15dbc06850a61e775822162654973ff95728bff6ba92
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like